Incidence of treatment intensification based on HbA1c trends in people with type 2 diabetes.

ABSTRACT:

Aims

Clinical inertia, the failure to intensify treatment despite unmet glycemic goals, is a key factor in poor glycemic management for type 2 diabetes. No studies have defined clinical inertia based on HbA1c trends. In this study, we aimed to assess treatment intensification according to HbA1c trends.

Materials and methods

We analyzed data from the Japan Diabetes Comprehensive Database Project based on an Advanced Electronic Medical Record System (J-DREAMS) between 2016 and 2023. Eligible patients with type 2 diabetes had (1) unchanged prescriptions for the past 90 days; (2) two consecutive consultations within 90 days; and (3) HbA1c levels ≥7%, or ≥7.5%, for patients aged ≥65 years at both consultations. Treatment intensification was defined as an addition or increased dos

SUBMITTER: Sugito E 

PROVIDER: S-EPMC12863005 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature